Integrated BioPharma, Inc. (INBP)
| Market Cap | 22.30M |
| Revenue (ttm) | 60.04M |
| Net Income (ttm) | 6.85M |
| Shares Out | 29.93M |
| EPS (ttm) | 0.21 |
| PE Ratio | 3.55 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,550 |
| Open | 0.799 |
| Previous Close | 0.800 |
| Day's Range | 0.741 - 0.799 |
| 52-Week Range | 0.270 - 1.240 |
| Beta | 0.27 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About INBP
Integrated BioPharma, Inc., together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States, Luxembourg, and Canada. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized healthcare providers. The Other Nutraceutical Businesses segment distributes healthful nutrition...
Financial Performance
In 2021, INBP's revenue was $63.56 million, an increase of 20.45% compared to the previous year's $52.77 million. Earnings were $8.01 million, an increase of 95.06%.
Financial StatementsNews
Integrated BioPharma Reports Results for its Quarter Ended March 31, 2022
HILLSIDE, NJ / ACCESSWIRE / May 12, 2022 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the fiscal quarter ended March 31, 2022. Revenue for the th...
Integrated BioPharma Reports Results for its Quarter Ended December 31, 2021
HILLSIDE, NJ / ACCESSWIRE / February 10, 2022 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended December 31, 2021. Revenue for the q...
Integrated BioPharma Reports Results for its Quarter Ended September 30, 2021
HILLSIDE, NJ / ACCESSWIRE / November 10, 2021 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended September 30, 2021. Revenue for the ...
Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2021
HILLSIDE, NJ / ACCESSWIRE / September 2, 2021 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter and fiscal year ended June 30, 2021. Reven...
OTC Markets Group Welcomes Integrated BioPharma, Inc. to OTCQX
NEW YORK, Jan. 22, 2021 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 11,000 U.S. and global securities, today announced Integrated BioPharma, Inc. (OTCQX: INBP...